NCT07003139View on ClinicalTrials.gov

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Malignant Brain Tumors
Interventions
DRUG

B10 L-BPA Injection

The investigational product is B10 L-BPA Injection, is a boron-containing compound in which 10B replaces a position on L-phenylalanine at the para position with dihydroxyboron.

Trial Locations (1)

40447

RECRUITING

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Heron Neutron Medical Corp.

INDUSTRY

lead

China Medical University Hospital

OTHER

NCT07003139 - A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors | Biotech Hunter | Biotech Hunter